Metabolic Tests Ignored in Medicaid Patients on Antipsychotics (CME/CE): “Antipsychotic-induced metabolic disturbances receive little attention among Medicaid patients treated with second-generation antipsychotics, according to an analysis of more than 100,000 cases.”
Antipsychotic-induced metabolic disturbances receive little attention among Medicaid patients treated with second-generation drugs, according to an analysis of more than 100,000 cases.
Slightly more than a [...]
From the category archives: